– USA, WA – Rippl, a new kind of behavioral health company focused on dramatically expanding access to high-quality, wrap-around care for seniors with neurocognitive challenges, today announced the additions of Iyah Romm and Ryan Watts to its Board of Directors.
About Iyah Romm
Romm has been a formal advisor to Rippl since November 2022 and has built a career pioneering new and more innovative approaches to value-based care. Recognized and respected as one of the most gifted health-equity-focused innovators in the country, Romm has a long history of working for underserved populations. Before Cityblock, where he served as founding CEO until March 2022, and remains on the Board of Directors, Romm helped lead the Commonwealth Care Alliance in Massachusetts as Chief Transformation Officer and served as the founding Policy Director for Care Delivery Innovation and Investment at the Health Policy Commission, where he directly contributed to Massachusetts’ landmark health care reform efforts.
At Rippl, Romm will help architect the company’s approach to value-based care solutions that directly address the health disparities in senior populations with dementia and other neurocognitive challenges. Developing an equitable approach to expanding access and convenience to services within the large and growing population remains one of the company’s most important goals.
About Ryan Watts
As Co-founder and CEO of Denali Therapeutics, Watts is at the forefront of discovering and developing medicines for major neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS, most of which impact primarily senior populations. In addition to his role as CEO, Watts is also the Co-founder, President, and member of the Board of Directors at Denali. Before his time at Denali, Watts served as the Director of the Department of Neuroscience at Genentech, where he led drug discovery for Alzheimer’s disease.
Watts has spent the majority of his career in neurocognitive spaces, honing a deep knowledge and understanding of the science, research, and therapeutics landscape. At Rippl, Watts will utilize his front-row seat to future disease therapies to better position Rippl to serve dementia patients, crafting an evolved care model that can optimize future solutions and care.
About Rippl
Rippl is a new mental health company focused on seniors and obsessed with its clinicians. Seniors with behavioral health challenges, especially neurocognitive conditions like Alzheimer’s disease and other dementias, are overlooked and under-cared for, often without access to high-quality, real-time, practical care. Leveraging a value-based approach, disruptive technology, and a relentless focus on empowering and enabling its clinicians, Rippl is pioneering a new care model to dramatically expand access to high-quality, wraparound behavioral health care for seniors, their families, and caregivers. Founded by a group of impatient optimists and doers from the country’s most iconic health care and consumer brands (who have all been caregivers themselves), and backed by visionary venture investors ARCH Venture Partners, General Catalyst, GV, F-Prime Capital, and Mass General Brigham, Rippl is ready to take this urgent challenge head-on. Our seniors deserve so much better.
For more information: https://ripplcare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
